The influence of finasteride on the development of prostate cancer.
Published in The New England journal of medicine • Jul 17, 2003
Authors:,,
Ian M Thompson
Phyllis J Goodman
Catherine M Tangen
Abstract
BACKGROUND: Androgens are involved in the development of prostate cancer. Finasteride, an inhibitor of 5alpha-reductase, inhibits the conversion of testosterone to dihydrotestosterone, the primary androgen in the prostate, and may reduce the risk of prostate cancer. METHODS: In the Prostate Cancer P...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!